Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Treatment Aided by Automated Analysis of Fluid in Active Neovascular Age-related Macular Degeneration (nAMD) in a Prospective, Multicenter, Randomized Study.

NCT05093374 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT05093374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05093374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Treatment Aided by Automated Analysis of Fluid in Active Neovascular Age-related Macular Degeneration (nAMD) in a Prospective, Multicenter, Randomized Study.
Lead sponsor
Medical University of Vienna
Phase
Phase 4
Overall status
Recruiting
Start date
March 1, 2021
Completion date
December 31, 2025
Enrollment
290 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

exudative macular degeneration